Hypothyroidism vs. Hashimoto's: what's different and what's similar! - Stop The Thyroid Madness

Hypothyroidism vs. Hashimoto's: what's different and what's similar! - Stop The Thyroid Madness

pin 64
heart 3
This lesson will define examine the function of a hormone and the glands within the endocrine system.

This lesson will define examine the function of a hormone and the glands within the endocrine system.

BPA (know endocrine disruptor, and also linked to cancer) found in plastics (such as bottles) has been shown to also narrow arteries, which can lead to a heart attacks -- Another reason to rise above plastics!

BPA (know endocrine disruptor, and also linked to cancer) found in plastics (such as bottles) has been shown to also narrow arteries, which can lead to a heart attacks -- Another reason to rise above plastics!

According to the Safer Chemicals Healthy Families' blog, "FDA agrees to set regulation on toxic triclosan" (after having been sued). "Depending on how the FDA defines consumer hand products, it could be restricted in hand soap, hand sanitizers etc." http://blog.saferchemicals.org/2013/12/fda-agrees-to-set-regulation-on-toxic-triclosan-.html #thyroid #LearningDisabilities #infertility #liver #endocrine

According to the Safer Chemicals Healthy Families' blog, "FDA agrees to set regulation on toxic triclosan" (after having been sued). "Depending on how the FDA defines consumer hand products, it could be restricted in hand soap, hand sanitizers etc." http://blog.saferchemicals.org/2013/12/fda-agrees-to-set-regulation-on-toxic-triclosan-.html #thyroid #LearningDisabilities #infertility #liver #endocrine

pin 2
Type 2 Diabetes Treatments * You can find more details by visiting the image link.

Type 2 Diabetes Treatments * You can find more details by visiting the image link.

pin 5
"European Commission Proposal Leaves Public Exposed to Harmful Endocrine Disrupting Chemicals - The Endocrine Society expressed disappointment today in the European Commission's revised proposal on defining and identifying endocrine-disrupting chemicals (EDCs), citing unnecessarily narrow criteria for identifying EDCs that will make it nearly impossible for scientists to meet the unrealistically high burden of proof and protect the public from dangerous chemicals."

"European Commission Proposal Leaves Public Exposed to Harmful Endocrine Disrupting Chemicals - The Endocrine Society expressed disappointment today in the European Commission's revised proposal on defining and identifying endocrine-disrupting chemicals (EDCs), citing unnecessarily narrow criteria for identifying EDCs that will make it nearly impossible for scientists to meet the unrealistically high burden of proof and protect the public from dangerous chemicals."

In 1902, Ernest Starling discovered secretin, a protein that is considered by many to be the 1st isolated hormone.  Starling went on to define hormones as “chemical messengers, which are carried from the organ where they are produced to the organ which they affect by means of the blood stream.”   This discovery would spawn a revolution of biomedical thought and successful treatments for a long list of endocrine diseases.

In 1902, Ernest Starling discovered secretin, a protein that is considered by many to be the 1st isolated hormone. Starling went on to define hormones as “chemical messengers, which are carried from the organ where they are produced to the organ which they affect by means of the blood stream.” This discovery would spawn a revolution of biomedical thought and successful treatments for a long list of endocrine diseases.

Neonatal hypoglycemia, defined as a plasma glucose level of less than 30 mg/dL (1.65 mmol/L) in the first 24 hours of life and less than 45 mg/dL (2.5 mmol/L) thereafter, is the most common metabolic problem in newborns.

Neonatal hypoglycemia, defined as a plasma glucose level of less than 30 mg/dL (1.65 mmol/L) in the first 24 hours of life and less than 45 mg/dL (2.5 mmol/L) thereafter, is the most common metabolic problem in newborns.

[Clinical Study] Tumour recurrence and enlargement in patients with #craniopharyngioma with and without GH replacement therapy during more than 10 years of follow-up (full text) (published European Journal of Endocrinology, June 1, 2012 166 1061-1068)

[Clinical Study] Tumour recurrence and enlargement in patients with #craniopharyngioma with and without GH replacement therapy during more than 10 years of follow-up (full text) (published European Journal of Endocrinology, June 1, 2012 166 1061-1068)

pin 1
Pinterest • The world’s catalogue of ideas
Search